检索结果-南通市图书馆

突尼斯腿部丹毒患者危险因素的多中心病例对照研究

在线全文

学校读者我要写书评

暂无评论

引用

世界核心医学期刊文摘（皮肤病学分册） 2006年第4期2卷 44-44页

作者： Mokni M. Dupuy A. Denguezli M. o. chosidow 罗素菊徐波 Department of Dermatology and Allergology Hopital Tenon 4 rue de la Chine FR- 75020 Paris FranceProf.

Background: Risk factors for erysipelas (cellulitis) were rarely evaluated in controlled studies. Regional variations of these risk factors have never be assessed. objective: To assess risk factors for erysipelas of the leg in Tunisia. Subjects and Methods: Case- control study in seven hospital centers in Tunisia. Cases were 114 consecutive patients with erysipelas of the leg [sudden onset (of a well- demarcated dermo- hypodermatitis with fever or chills]. Two controls were matched to each case for age, sex, and hospital (n=208). Main outcome measures are local and general suspected risk factors for erysipelas of the leg. Results: In multivariate analysis, disruption of the cutaneous barrier (i.e. traumatic wound, toe- web intertrigo, excoriated leg dermatosis or plantar squamous lesions) and leg edema were independently associated with erysipelas of the leg, with respective odds ratios of 13.6 (95% confidence interval: 6.0- 31) and 7.0 (1.3- 38). No association was observed with diabetes, alcoholism, or smoking. Conclusions: We confirmed the major role of local risk factors and the minor role of general risk factors for erysipelas of the leg, in a setting different than the one previously studied. Detecting and treating toe- web intertrigo and traumatic wounds should be considered in the prevention of erysipelas of the leg.

关键词：病例对照研究表皮剥脱皮肤屏障趾间蜂窝织炎性创伤多变量分析

肿瘤坏死因子α抑制剂治疗皮肤结节病的疗效及耐受性观察:来自法国的一项46例病例研究

在线全文

学校读者我要写书评

暂无评论

引用

皮肤性病诊疗学杂志 2017年第4期24卷 300-300页

作者： Heidelberger V Ingen-Housz-oro S Marquet A Mahevas M Bessis D Bouillet L Caux F Chapelon-Abric C Debarbieux S Delaporte E Duval-Modeste AB Fain o Joly P Marchand-Adam S Monfort JB Noёl N Passeron T Ruivard M Sarrot-Reynauld F Verrot D Bouvry D Fardet L chosidow o Sève P Valeyre D 邓婕张锡宝 Department of Dermatology AP-HP Hôpital Henri Mondor Créteil France. Department of Dermatology AP-HP Hôpital Henri Mondor Créteil France2Department of Dermatology EA 7379 - EpiDermE Université Paris Est Créteil France. Department of Internal Medicine Hôpital de la Croix-Rousse Lyon France. Department of Internal Medicine APHP Hôpital Henri Mondor Créteil France. Department of Dermatology Hôpital Saint-Eloi Montpellier France. Department of Internal Medicine Centre hospitalier universitaire de Grenoble-Alpes Grenoble France. Department of Dermatology APHP Hôpital Avicenne Bobigny France. Department of Internal Medicine APHP Hôpital de la Pitié-Salpêtrière Paris France. Department of Dermatology Centre hospitalier Lyon-Sud Lyon France. Department of Dermatology Hôpital Claude Huriez Lille France. Department of Dermatology Hôpital Charles Nicolle Rouen France. Department of Internal Medicine APHP Hôpital Saint-Antoine Paris France. Department of Pneumology Hôpital Bretonneau Tours France. Department of Dermatology APHP Hôpital Tenon Paris France. Department of Internal Medicine APHP Hôpital Bicêtre Le Kremlin-Bicêtre France. Department of Dermatology Hôpital de l'Archet Nice France. Department of Internal Medicine Hôpital Estaing Clermont-Ferrand France. Department of Internal Medicine Hôpital Saint-Joseph Marseille France. Department of Pneumology APHP Hôpital Avicenne Bobigny France. Department of Dermatology AP-HP Hôpital Henri Mondor Créteil France2Department of Dermatology EA 7379 - EpiDermE Université Paris Est Créteil France20Department of Dermatology Université Paris Est UPEC Créteil France.

法国一项回顾性和前瞻性多中心研究对肿瘤坏死因子α抑制剂（anti-tumor necrosis factorα,TNFα抑制剂）治疗皮肤结节病的疗效和安全性做出了观察报告。自2004年1月~2016年1月期间,患者来自于多个教学医院、转诊中心、肺科、皮肤科和... 详细信息

法国一项回顾性和前瞻性多中心研究对肿瘤坏死因子α抑制剂（anti-tumor necrosis factorα,TNFα抑制剂）治疗皮肤结节病的疗效和安全性做出了观察报告。自2004年1月~2016年1月期间,患者来自于多个教学医院、转诊中心、肺科、皮肤科和内科,病理确诊为结节病,并接受抗-TNFα治疗。对治疗反应的评估使用肺外器官严重度评分（ePoST,0为不受影响,6为非常严重）。

关键词：皮肤结节肿瘤坏死因子α 教学医院病例研究观察报告严重度结节病

重症监护病室重症腹膜炎患者死亡率的预测因素

在线全文

学校读者我要写书评

暂无评论

引用

德国医学 2001年第5期18卷 309-309页

作者： Dupont H Paugam-Burtz.C.Muller-Serieys C.chosidow 关键方善德华中科技大学同济医学院附属同济医院

简介:重症腹膜炎死亡率的预测因素有待明确.公开发表的研究文件多数集中于不需进入重症监护病室(ICU)治疗的中度腹膜炎.本研究的目的是要确定患有严重腹膜炎的ICU患者死亡率的预测因素.方法:作者对1994年～1999年间诊断为腹膜炎被收入外... 详细信息

简介:重症腹膜炎死亡率的预测因素有待明确.公开发表的研究文件多数集中于不需进入重症监护病室(ICU)治疗的中度腹膜炎.本研究的目的是要确定患有严重腹膜炎的ICU患者死亡率的预测因素.方法:作者对1994年～1999年间诊断为腹膜炎被收入外科ICU的患者(社区获得性或术后腹膜炎)进行了前瞻性研究.比较存活者(S)与未存活者(NS)的人口学、微生物学数据和后果,采用Mann-Whitney和CHi平方检验进行无变量分析.多变量分析则用分步逻辑回归方案.计算出机率与95%的可信区间(95%CI).P＜0.05时有显著性.

关键词：重症监护病害重症腹膜炎死亡率预测